- Sort by Product ID
- Display 30 Products per page
Published: December 29, 2023 | Price: $5,000.00 – $10,000.00
Liquid biopsies have emerged as a minimally invasive diagnostic tool, analyzing tumor-derived materials circulating in biological fluids to offer valuable information for cancer diagnosis, treatment, and monitoring. While tissue biopsies and imaging techniques remain standard in solid tumor diagnosis, liquid biopsies present an alternative or complementary approach, addressing some of the limitations and risks associated with traditional methods. Key applications of liquid biopsy testing in clinical oncology include: Early Detection and Diagnosis/Screening: Identifying cancer at an early stage. Alternative Testing...Published: September 8, 2023 | Price: $5,000.00 – $10,000.00
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...Published: April 3, 2023 | Price: $5,000.00 – $10,000.00
The Market for Single Cell Analysis in Genomics: Next-Generation Sequencing and Other Technology, 2023-2027 focuses on the market for single cell genomics products. Analyzed are the hardware, service of the hardware, software, and consumables included for the sequencing step and other types of downstream analysis. Single cell RNA-seq enables new types of analyses, for instance: understanding tumour heterogeneity and clonal evolution (including studying lineage analysis, cancer stem cells, and drug-resistant and metastatic clones), understanding complex tissues (e.g. neural tissues), high resolution...Published: December 29, 2022 | Price: $6,000.00 – $12,000.00
Dramatic changes have occurred in the liquid biopsy market, necessitating a resource to provide perspective on the market opportunity. This new report from Kalorama assesses the Liquid Biopsy Market now and in 2027. The report can be useful for business planning, market share assessment, competitive research, and due diligence for mergers and acquisitions and other partnerships. Liquid biopsy is gaining acceptance each year. Even through the COVID-19 pandemic, announcements of new liquid biopsy products were made and studies conducted to...Published: September 7, 2022 | Price: $0.00 – $9,000.00
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...Published: August 29, 2022 | Price: $7,500.00
This report, produced by Bioinformatics Inc. (not part of Kalorama subscriptions) is a recent survey of 350 respondents from North America, Europe and Asia Pacific that use social media and/or science-related websites for personal or professional purposes participated in this study Readers of this study will understand: Understand the technologies used for isolation of single cells in 2022 Evaluate the kit and instrument suppliers used for single cell experiments Understand the pain points currently experienced with single cell experiments and areas...Published: May 5, 2022 | Price: $6,000.00 – $12,000.00
Single Cell Analysis in Next-Generation Sequencing Markets (Market Size and Forecast, Segment Breakouts, Secondary Research), 2022-2027 focuses on the market for single cell genomics products -- the hardware, service of the hardware, software, and consumables including for the sequencing step and other types of downstream analysis. It discusses trends, challenges, strategies, companies, and products, and provides estimates of market share and revenue growth for the market. The competitive situation, deals, and products are covered in respective chapters. Historical data for...Published: January 6, 2022 | Price: $5,000.00 – $10,000.00
This report, The World Liquid Biopsy Market, 2021, from Kalorama Information, contains up-to-date information and useful data points for business planning: Research vs. Clinical Liquid Biopsy The Market for Liquid Biopsy by Region The Market for Liquid Biopsy Market by Type of Analyte The Market for CTC-based Liquid Biopsy The Market for ctDNA-based Liquid Biopsy The Market for EV and Exosome-based Liquid Biopsy The Market for Multi-Analyte-based Liquid Biopsy The Market for Other Liquid Biopsy Liquid Biopsy Market by Type...Published: January 1, 2022 | Price:
How Do You Plan to Keep Up With Developments in The Business of Cell and Gene Therapy in 2022? Consider Cell and Gene Therapy Business Outlook Each week brings news in Cell and Gene Therapy, from advances in clinical trials to product launches, from tools development to mergers and acquisitions. It can be a daunting task to keep up. Yet these developments are too fast-moving and significant for healthcare companies of any type to ignore. Now from Science and Medicine...Published: December 20, 2021 | Price: $3,000.00 – $6,000.00
Viral vectors are useful tools used by molecular biologists to delivery genetic material into cells. Kalorama Information’s Viral Vectors Market Analysis and Opportunities reveals that viral vectors comprise a rising market that is expected to continue to grow as usage increases and novel technologies enter the market. Viral vectors are the most effective means of gene transfer to modify specific cells or alter the expression of therapeutic genes. The choice of viral vector depends on the efficiency of transgene expression,...Published: August 30, 2021 | Price:
More than 42,000 Instruments at over 5,000 Facilities across a Dozen Modalities — 12 Month License with Quarterly Refresh Download Brochure The most comprehensive database of installed clinical diagnostic equipment in the U.S. The Kalorama Information MasterFile contains detailed information on more than 5,300 hospitals and testing facilities and over 42,000 clinical diagnostic instruments across 12 modalities: Blood Gas Analyzers Chemistry Coagulation HbA1c Hematology Immunoassay Integrated Chem/Immuno Mass Spectrometry Microbiology AST ID Microbiology Blood Culture Molecular Diagnostics Next-Generation Sequencing Urinalysis Analyzers...Published: July 28, 2021 | Price: $4,000.00 – $8,000.00
The Market for Library Preparation and Target Enrichment for Next-Generation Sequencing This report, Market for Library Preparation and Target Enrichment for Next-Generation Sequencing (NGS) examines the current market, providing a comprehensive market summary, including NGS sample preparation revenues and growth rates for 2021-2026 and NGS sample preparation revenues by geographic region for 2020 (North America, Europe, Asia-Pacific, rest-of-world). The introduction of smaller, cheaper benchtop NGS systems has expanded the market into smaller labs that could never afford prices for earlier...Published: December 23, 2020 | Price: $5,500.00 – $11,000.00
The study of individual cells has long been an important part of biological research. Historically this has been a very manual process; some automated technologies are available. The need for microscopy and other traditional methods has remained, as new methods have also arrived, all of which have been gradually improved. The ability to amplify DNA or RNA from an individual cell was a key development. As a result of continuous technological advances in the last 15 years, the use of...Published: August 24, 2020 | Price: $5,500.00 – $11,000.00
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...Published: May 14, 2020 | Price: $4,000.00 – $8,000.00
CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the fields of molecular diagnostics, vaccines and telehealth for decades. These important industries, already growing in revenues and number of competitors, now find themselves part of...Published: May 8, 2020 | Price: $5,500.00 – $11,000.00
Outsourcing drug discovery is the beginning phase of the drug development process. Through outsourcing portions of their drug discovery programs, many pharmaceutical and biotechnology companies have found an effective cost-cutting strategy that can also improve the hit-to-lead conversion and early identification of unsuccessful compounds. In view of the fact that outsourcing can accelerate the drug discovery process, the business of contract drug discovery has evolved from providing low-end research services to more value-added high-end research. Outsourcing in Drug Discovery provides...Published: April 27, 2020 | Price: $5,500.00 – $11,000.00
What is the Size of the Cell and Gene Therapy Market? According to the latest report on the cell and gene therapy market from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3,866 million And most of the market is for the treatment of cancer. Dermatological, Cardiovascular – Blood, Oncology, Ophthalmic, Musculoskeletal and other conditions. With the COVID-19 crisis, there are some efforts to adapt this promising technology to the treatment and...Published: April 21, 2020 | Price: $4,000.00 – $8,000.00
The vaccine market is poised for a rather substantial increase in the next five years due to the number of vaccines in development and the push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, companies stepped up to the challenge, scrambling to provide a potential vaccine. In addition to discussion of COVID-19 vaccine development as it stands currently, this report examines the market for human vaccines used to prevent various types of disease, focusing on commercialized vaccines and...Published: April 7, 2020 | Price: $750.00 – $1,000.00
For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: It's important to note that the entire molecular testing concept originated in the midst of a crisis, at that time...Published: January 6, 2020 | Price: $2,000.00 – $4,000.00
Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD). NASH is characterized by inflammation in the liver and liver cell damage, which can lead to scarring of the liver (cirrhosis). No medications have been approved specifically for NASH but there are numerous products in development. NASH Drug Pipeline and Market Overview looks at the almost 80 drug candidates for the treatment of this disease in terms of developer, type of drug, phase study, and market entrance estimate....Published: December 19, 2019 | Price: $4,000.00 – $8,000.00
CAR-T cell therapy is a form of immunotherapy that utilizes the body’s own T cells to target and destroy cancer cells. This therapy is a personalized form of treatment, meaning that each patient receives T cells that are geared specifically toward his or her cancer diagnosis. T-cell therapy works by removing existing T cells from a patient and having them grown and modified in a lab. These new T cells are given a gene for a specialized receptor, known as...Published: November 25, 2019 | Price: $4,000.00 – $8,000.00
The increasing popularity of next-generation systems has fueled systems and sequencers, but the cost of sequencing – despite price declines – has led to demands for more efficient methods. Exome Sequencing is a widely used NGS technique that sequences all the exons in a genome. Rather than sequencing the entire human genome, only pieces of an individual's DNA that provide instructions for making proteins are sequenced. These pieces, called exons, are thought to make up roughly 2 percent of a...Published: August 2, 2019 | Price: $6,000.00 – $12,000.00
Next-generation sequencing (NGS) technologies encompass the modern, post-Sanger sequencing techniques that revolutionized and expanded the fields of molecular biology and genomics in recent years. NGS has been a disruptive technology that had a substantial impact on the characterization of the genome of various species, and has found numerous applications in a large variety of fields, including clinical diagnostics, drug discovery and development, agriculture, and forensics. Next-Generation Sequencing Markets provides an in-depth look at the sequencing market, including data for 2018-2023...Published: May 30, 2019 | Price: $5,500.00 – $11,000.00
Liquid biopsies are a set of minimally invasive diagnostic methods that analyze tumor-derived materials that can be found circulating in biological fluids, to provide information for the diagnosis, treatment, and monitoring of cancer. This report, The World Liquid Biopsy Market, from Kalorama Information, contains up-to-date information and useful data points for business planning: Research vs. Clinical Liquid Biopsy The Market for Liquid Biopsy by Region The Market for Liquid Biopsy Market by Type of Analyte The Market for CTC-based Liquid...Published: May 8, 2019 | Price: $3,000.00 – $6,000.00
Biopharmaceuticals are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies, and nucleic acids such as DNA or RNA. Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. However, biosimilars are not generic biologics because there can be no generic form of biologics due to the complex process of creating biologics. Biosimilar Market Trends 2019 is designed to provide a snapshot of issues and trends that are affecting the biosimilar market...Published: December 10, 2018 | Price: $4,500.00 – $9,000.00
Global Cell Culture Markets (Media, Sera, Reagents) Growth in the use of cell culture for biological research, vaccine production, the production of therapeutic proteins, and emerging regenerative medicine applications are driving the global cell culture market. As second generation biologics such as monoclonal antibodies replace first generation therapeutic proteins, there is also an increased demand for more advanced in vitro cell culture techniques with greater growing capacities. This report is focused on cell culture used in the research and production...Published: November 12, 2018 | Price: $4,500.00 – $9,000.00
World Market for Biopharmaceutical Drug Delivery Device Technology The total market for biopharmaceutical drug delivery is very complex and shifting due to technological advancements. Though the market to date has been dominated by injectable administration, injections are not the first choice among patients and compliance is an ongoing issue. Further, as the majority of new entities in development are biologics requiring advanced drug delivery, manufacturers of devices have been busy developing new innovations that will meet the current needs of...Published: October 2, 2018 | Price: $4,500.00 – $9,000.00
Downstream Bioprocessing Markets (Chromatography Columns and Resins, Membrane Adsorbers, Filtration Systems, Sensors) Downstream processing, or bioprocessing, involves the recovery and purification of biosynthetic products, often pharmaceuticals, from natural sources. These sources may be animal or plant tissue or fermentation broth. It is an essential step in producing pharmaceuticals, such as antibiotics, hormones (insulin and human growth hormone), antibodies, and vaccines. Downstream Bioprocessing Markets analyzes the current and potential world market for components used in downstream processing, including the global downstream...Published: September 7, 2018 | Price: $4,500.00 – $9,000.00
The Market for Library Preparation and Target Enrichment for Next-Generation Sequencing Market for Library Preparation and Target Enrichment for Next-Generation Sequencing (NGS) examines the current market, providing a comprehensive market summary, including NGS sample preparation revenues and growth rates for 2017-2022 and NGS sample preparation revenues by geographic region for 2017 (North America, Europe, Asia-Pacific, rest-of-world). As NGS science continues to evolve, the report examines trends in the market, including the gradual acceptance and validation of clinical applications, China becoming...Published: May 4, 2018 | Price: $4,500.00 – $9,000.00
Single Use Upstream Bioprocessing Markets (Bioreactors, Media Bags, Bioprocess Containers, Tubing and Connectors, Mixing Systems, Sensors and Probes) Single Use Upstream Bioprocessing Markets (Bioreactors, Media Bags, Bioprocess Containers, Tubing and Connectors, Mixing Systems, Sensors and Probes) analyzes the current and potential world market for single use systems for upstream bioprocessing. This report generally reviews the nature and direction of research, as well as future markets. Market forecasts cover various segments from 2016-2021, including global revenues for single use upstream processing;...